CAFs remodel the ECM and enhance tumor cell invasiveness by secreting cytokines (e.g., TGF-β, IL-6) and chemokines (e.g., CCL2, CXCL12), promoting angiogenesis and inducing EMT. This evidence concerns the gene CCL2 and neoplasm.